Previous studies have indicated the oncogenic role of USP29 in several cancer types, including the non-small cell lung cancer [37], colorectal cancer [38], hepatocellular carcinoma [23] and triple-negative breast cancer [24]. This evidence concerns the gene USP29 and triple-negative breast carcinoma.